China FDA Adds to List of Medical Devices, IVDs Exempt from Clinical Trials
Questions? Request more information from our specialists
CONTACT USJul 24, 2018
EMERGO SUMMARY OF KEY POINTS:
- Chinese regulators have added additional Class II and III medical devices as well as some Class III IVD devices to their list of products exempted from clinical trial requirements.
- Devices in the latest batch of exemptions include lancets, anesthesia needles and incubators.
The China Food and Drug Administration (CFDA) has drafted a new batch of medium- and high-risk medical devices and IVDs slated for exemption from clinical trial requirements in the country.
CFDA’s latest draft publication (link in Chinese) includes a fourth batch of Class II and III medical devices such as arteriovenous lancets, aneurysm clips, anesthesia needles and incubators; the draft also includes a third batch of Class II IVDs, as well as the first batch of Class III IVDs to potentially be exempt from clinical trials.
In addition, CFDA has issued a draft compilation catalogue covering the first three batches of Class II and III device exemption lists that incorporate revisions laid out in the regulator’s new classification catalogue published in late 2017.
More Chinese medical device regulatory resources:
- China CFDA medical device registration and approval consulting
- CFDA clinical and testing requirements assessment
Author
- Teemo Chang and Stewart Eisenhart
Related
China FDA Changing Medical Device, IVD Submission Requirements
EMERGO SUMMARY OF KEY POINTS:
- The China Food and Drug Administration (CFDA) plans to ease certain requirements for registration renewals and clinical trial application processes.
- CFDA also intends to launch a more robust electronic registration submission system for market applicants.
- Implementation of these plans would result in less onerous Chinese market entry pathways for foreign device manufacturers.
More Details on Changes to China FDA Medical Device Clinical Requirements
EMERGO SUMMARY OF KEY POINTS:
- The China Food and Drug Administration (CFDA) has published new technical guidance on accepting medical device clinical data from sources outside China.
- Foreign clinical data used in CFDA registration applications must meet China Good Clinical Practice requirements.
- Chinese market registrants should notify CFDA before submitting applications that they intend to use foreign clinical data in their applications.